MASSDEVICE ON CALL —Brazilian device maker Braile Biomedica announced the launch of its Inovare transcatheter aortic valve replacement system this week.
The device won approval from Brazilian regulators in November 2011 after hitting clinical endpoints in 93% of procedures in the company’s clinical trials.
In a study of about 150 patients, more than ¾ of which were considered at high risk for surgery while the rest were inoperable, there were 3 deaths within 30 days and mortality rose to 50% at 2 years for the 79 patients for whom data was available, according to TheHeart.org.
The device is only approved for transapical procedures, according to the news outlet, but Braile is also looking to gain approval for a transfemoral approach.
Trouble at FDA advisory committees?
Recent outbursts at FDA advisory committees raised eyebrows about whether the panels are following their own rules, Medical Device Daily reported.
First medical device accelerator now taking applications
Memphis, Tenn.-based ZeroTo510 is offering up to $150,000 in funding and support to help medical device makers in a first-of-its-kind accelerator program designed for the med-tech industry, according to a press release.
Recession and high co-pays drive down demand for colonoscopies amid insured patients
Even insured patients have cut back in health care expenses during the economic recession, illustrated by the drop in demand for the cost-effective and highly recommended regular colonoscopy screenings, according to a press release.
Computer assisted tools help pediatricians detect obesity
Electronic health records may be the latest tools in the fight against childhood obesity in a large population rather than on an individual family basis, according to a press release.
